An outpatient procedure may offer a way for the estimated 70% of people who discontinue popular weight-loss drugs to avoid ...

Retatrutide shows big weight loss potential but isn’t FDA-approved. Here’s what to know about its safety and legal risks.

Ways to support our beautiful but fragile planet, why police still struggle to end shootings during mental health calls, and ...

The company's new GLP-1 program will offer both oral and injectable medications Courtesy Amazon Amazon has launched a new GLP ...

Amazon One Medical has launched a GLP-1 management program that integrates primary care, pharmacy services and virtual care ...

The company argues the offering is a more comprehensive approach to weight management, allowing patients to receive ongoing ...

Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...

The FDA has approved the second GLP-1 pill for overweight and obesity. How does it compare to the Wegovy oral pill?

Experts warn popular GLP‑1 drugs may pose added risks for some patients, highlighting the need for medical supervision.

You finally took the plunge and started taking a GLP-1 drug to improve your health. You’re keeping up with your GLP-1 pill or ...

As technology becomes more integrated and personalized, experts say the biggest opportunity in diabetes management is ...

Hims & Hers Health (NYSE:HIMS) shares are up 9% in early trading Monday, climbing from $28.82 to $31 and change as investors ...